公司资料
Protagenic Therapeutics 股价、新闻与催化剂
- 股票代码:
- PTIX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.36 USD (0.00%)
收盘价
最后更新: 2026年8月14日
—
市值
股价为何变动
Current closing-price context is not available for PTIX.
公司概览
业务概览
Protagenic Therapeutics is a biotechnology company focused on neuropsychiatric and stress-related disorders. Its story is built around the idea that peptide-based or related approaches can address difficult CNS conditions.
所在地与行业分类
Protagenic is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
商业模式特征
The company depends on preclinical and early clinical validation, translational credibility, and capital support. Investors typically watch early data, pipeline prioritization, and whether the company can narrow its story into a viable CNS thesis.
生物医药行业定位
Protagenic occupies a speculative neuroscience niche within biotech. It is a high-risk story where platform proof matters more than near-term commercial scale.
未来催化剂
- Protagenic’s catalysts are neuropeptide and CNS programs, with any update that clarifies whether the company can still produce meaningful development progress. The stock needs a cleaner clinical path.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。